Reply to M.G. McNamara et al and M.S. Copur et al
- PMID: 26124483
- DOI: 10.1200/JCO.2015.61.8298
Reply to M.G. McNamara et al and M.S. Copur et al
Comment on
-
Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.J Clin Oncol. 2015 Jan 20;33(3):244-50. doi: 10.1200/JCO.2014.56.2728. Epub 2014 Nov 3. J Clin Oncol. 2015. PMID: 25366685 Free PMC article. Clinical Trial.
-
To BRCA or Not to PALB.J Clin Oncol. 2015 Aug 10;33(23):2581-2. doi: 10.1200/JCO.2014.60.0585. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124473 No abstract available.
-
Germline BRCA1/2 Mutations: Are They Good Enough to Determine Who Will Respond to Poly(ADP-Ribose) Polymerase Inhibitor Therapy in Advanced Cancer?J Clin Oncol. 2015 Aug 10;33(23):2582. doi: 10.1200/JCO.2015.61.0576. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124479 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
